Connect to share and comment

Drugstore chain Walgreen's profit slips as generic drug benefit wanes, frigid winter bites

Walgreen's fiscal second quarter earnings slipped from a year ago as the nation's largest drugstore chain reaped a smaller benefit from generic drugs and took a $60 million hit due to rough winter weather. But the Deerfield, Ill., company's underlying performance impressed investors, and its shares rose, approaching the all-time high that they reached last month. Walgreen executives said Tuesday that a wave of new generic drug introductions peaked in last year's quarter, which helped the company's bottom line then but made comparisons difficult for this year's quarter.

Walgreen offers month of prescriptions to backlogged Obamacare enrollees

(Reuters) - Walgreen Co said on Monday it will provide a month's supply of certain prescriptions at no upfront cost to U.S. participants who have not yet received a plan identification number under President Barack Obama's signature healthcare law.

Walgreen offers month of prescriptions to backlogged Obamacare enrollees

(Reuters) - Walgreen Co said on Monday it will provide a month's supply of certain prescriptions at no upfront cost to U.S. participants who have not yet received a plan identification number under President Barack Obama's signature healthcare law.

Drugstore chain Walgreen reports 68 per cent jump in fiscal 1Q profit, helped by Alliance Boots

Walgreen's fiscal first-quarter earnings soared 68 per cent as investments in other companies paid off for the nation's largest drugstore chain, but a slowdown in generic drug introductions helped squeeze profitability. The Deerfield Ill., company said Friday that it booked a total of $376 million in income during the quarter that ended Nov. 30 from its stakes in European health and beauty retailer Alliance Boots and U.S. pharmaceutical wholesaler AmerisourceBergen Corp.

Walgreen's fiscal 4th-quarter profit jumps 86 pct, helped in part by Alliance Boots deal

Walgreen Co.'s fiscal fourth-quarter earnings soared 86 per cent, as the nation's largest drugstore chain booked gains from its method of inventory accounting and its acquisition of a stake in European health and beauty retailer Alliance Boots. The Deerfield, Ill., company said Tuesday that it earned $657 million, or 69 cents per share, in the quarter that ended Aug. 31. That compares with earnings of $353 million, or 39 cents per share, a year ago. Revenue climbed 5 per cent to $17.94 billion.

Walgreen buying Kerr Drug's retail drugstores, specialty pharmacy business; price undisclosed

DEERFIELD, Ill. - Walgreen Co. plans to buy Kerr Drug's 76 retail drugstores and its specialty pharmacy business, a move that will help the nation's largest drugstore chain expand its North Carolina presence. The deal also includes a distribution centre, but does not include the long-term care pharmacy business of Kerr, a privately held regional chain. Financial terms were not disclosed. Kerr Drug's retail drugstores and specialty pharmacy business had fiscal 2012 sales of $381 million. In contrast, Walgreen recorded nearly $72 billion in revenue during fiscal 2012.

Drugstore chain Walgreen reports 16 per cent jump in fiscal 3Q profit, but misses estimates

Walgreen Co.'s fiscal third quarter earnings jumped 16 per cent, but its shares tumbled Tuesday as investors fretted over sluggish sales outside the drugstore chain's pharmacies and other troubling trends. The Deerfield, Ill., company missed Wall Street forecasts, and its earnings grew largely because of the comparison with last year's quarter, when a business split had hurt its performance.
Syndicate content